Jordan Wolfe
@next_gen66
Followers
3K
Following
2K
Media
326
Statuses
8K
focusing on technical analysis and swing trading Master of Financial Engineering | Bachelor of Computer Science
New York
Joined May 2011
$GMHS surged +95.58% 📈.Smart exit by our WhatsApp group members near the peak!. I’m now sharing real-time alerts on $IPDN, $NUKK, and other high-potential plays — for FREE. Join my inner circle:.👉 Message me after adding!.#TakeProfit
0
0
0
That's a wrap for today! Wishing everyone an amazing weekend — relax, recharge, and get ready for more action next week. 🚀.See you all Monday!
$AREB.Price Target: $1.10.Revenue growth is exceptionally strong. This is the company's greatest strength. Its year-over-year revenue growth rate has remained high in recent years, highlighting the company's successful expansion into emerging markets.
0
0
0
Today's plan is now live on WhatsApp. Our target is to achieve a 75-120% return. WhatsApp: After adding us, please send us a message so we can assist you promptly.
0
0
0
$SOGP.Expected increase of 15-40%. It has shown strong performance, breaking through resistance levels. Momentum signals remain persistent, indicating continued upward movement. Our team is prepared for this trend, representing another excellent entry opportunity. #BullMarket
1
0
0
$AREB.Price Target: $1.10.Revenue growth is exceptionally strong. This is the company's greatest strength. Its year-over-year revenue growth rate has remained high in recent years, highlighting the company's successful expansion into emerging markets.
1
0
1
Today's Stock Pick: $ALLR.Target Upside: $2.The ongoing Phase II clinical trial is currently enrolling patients with platinum-resistant ovarian cancer. Ovarian cancer is one of the most aggressive and difficult-to-treat cancers, with limited effective treatment options available.
1
1
18
Today's Stock Pick: $DEVS.Upside Potential: 10–25%.$DEVS offers a compelling alternative for large tech companies. Its platform helps media companies reduce reliance on and costs associated with major cloud providers for critical video streaming infrastructure. #TechStocks
0
1
2
Today's Recommendation: $ELAB.Target Price: $2.20. Exosomes represent a hot and rapidly developing frontier in medical aesthetics and skincare, attracting significant attention and investment while avoiding direct competition with mass-market consumer brands.#Biotech
1
0
0
Today's Stock Pick: $STSS. Expected Upside: 10-25%. $STSS's proprietary safety syringes (e.g., Securgardâ„¢) are FDA-approved and designed to protect healthcare workers from dangerous needle-stick injuries, addressing a critical issue in modern healthcare. #Biotech
1
0
0
Today's Focus Stock: $HCWB.Upside Potential: 15–40%.The company is a leader in the field of "inflammaging." Its innovative immunotherapies target chronic low-grade inflammation—a key driver of many age-related diseases, such as cancer.
0
0
0
Today's Stock Pick: $STSS.Price Target: $13.The company recently announced strong Q2 results, achieving record-high revenue. This impressive financial performance was driven by initial sales from its new product line and growing market demand for its products.
2
0
1
$CODI.Projected Growth: 10-45%.In short, investing in CODI is like gaining exposure to a curated portfolio of privately held companies across diverse industries, managed by a professional team.#TakeProfit
2
0
0
$ENSC.Projected Growth Rate: 10-30%.There is a critical need from both government and society for safer pain management solutions. Ensysce's technology precisely meets this essential demand. The FDA has explicitly encouraged the development of abuse-deterrent opioid analgesics.
1
0
0
Well done! It went even better than expected. Have a great weekend everyone!
$CODI. Price Target: $7.50. Holding stakes across multiple industries naturally reduces exposure to any single sector's risk. Publishing detailed financial performance reports for each subsidiary provides investors with clear visibility into capital allocation.
2
0
2
$HOTH.Projected Growth Rate: 15% - 40%.Target therapeutic areas address substantial patient populations and significant market opportunities. Any successfully commercialized drug candidate has the potential to drive exponential growth in company valuation.
0
0
3
$CODI. Price Target: $7.50. Holding stakes across multiple industries naturally reduces exposure to any single sector's risk. Publishing detailed financial performance reports for each subsidiary provides investors with clear visibility into capital allocation.
0
0
0
Emotional decisions during market volatility can lead to selling at a loss. Holding high-quality assets for the long term is crucial to weathering both bull and bear markets. Diversification can help reduce your risk exposure.
0
0
1
$ANGH Alert!.Key Price Levels:.Support: $3.15.Resistance: $3.43. Long? Buy near $3.15. Target Price: $3.50. Stop Loss: $3.10. Short? Sell near $3.43. Target Price: $3.00. Stop Loss: $3.50. Ready to act?
0
0
2